Defective Pharmaceuticals

The attorneys at Audet & Partners, LLP are dedicated to litigation involving dangerous pharmaceuticals and have collectively over a hundred years of representing injured persons and their family members. Our attorneys and staff on the firm’s pharmaceutical team are devoted to maximizing recovery for each and every one of our clients represented in ‘bad drug’ claims. Our firm employs the latest technology to advance our clients’ cases, from electronic record ordering to using a shared case program we have developed over time that allows us to represent groups of clients without losing our important one on one contact with individuals. In addition, our firm does not ‘collect’ clients for the sake of having more clients, but just the opposite: we carefully vet our potential clients, including clients referred to us by other firms. As a result, we are able to force large pharmaceutical companies and their well-financed defense firms to offer top dollar in any settlement based on the circumstances of our clients case. Unlike many other firms, we do not simply refer our cases to other firms. Instead, we internally litigate the cases and call on select co-counsel only when of overall benefit to our clients.

A review of our firm’s resume establishes Audet and Partners, LLP prominence among top-tier litigation and trial firms in the United States for dangerous pharmaceutical litigation. Over the past decade, we have been heavily involved in precedent setting cases (and multi-million dollar recoveries for our clients), including the Vioxx, Bextra and Transvaginal Mesh litigation. Our record speaks for itself and if you compare what our firm offers and what we can accomplish, you and your family can rest assured that Audet & Partners, LLP will aggressively prosecute your case from Day One.

If you believe that you or a loved one may have been injured as a result of a defective pharmaceutical, it is important that you retain an experienced lawyer promptly so that action may be initiated. At Audet & Partners, LLP, we work together with the nation’s leading experts in the fields of science and medicine to promptly investigate the defective product giving rise to your claim.

Too often in their efforts to rush new drugs onto the market, pharmaceutical manufacturers ignore safe practices and fail to conduct adequate testing that could have revealed the dangers of their products. In certain cases, drug manufacturers and medical device makers are aware of dangers associated with their products before ever placing them on the market.

Approval of a product by the FDA does not immunize the manufacturer from liability. Deaths and injuries can occur despite use of the drugs in accordance with manufacturers’ warnings and instructions. Some are the direct result of defective warnings and labels which fail to adequately warn of drug interactions, adverse reactions and serious side effects. Failure to provide instructions for safe use and/or withholding information regarding contraindications or preexisting conditions can increase the risk of injury. Others are caused by drugs which are recalled or withdrawn from the market, which were never safe to begin with, and which would not have been approved but for the manufacturer misleading or withholding material data from the FDA.

Defective Pharmaceuticals Investigations


Dietary Supplement Lawsuit Investigation Probes Hidden Amphetamine

Dietary Supplement Lawsuit

Audet & Partners, LLP is investigating widespread reports that dietary supplements purchased for several years at popular retailers contained hidden amounts of the amphetamine-like stimulant called BMPEA, or β-methylphenylethylamine.  IN 2013, the U.S. Food and Drug Administration ("FDA"), identified BMPEA in multiple supplements containing "Acacia rigidula" despite scientific evidence that BMPEA has never been identified or extracted from Acacia rigidula, a plant native to Texas. In recent years there has been mounting evidence of the dangers posed to humans by BMPEA.  In... Read More

Depakote and Birth Defects

Depakote Lawsuit Information Children born to women taking the commonly prescribed seizure medication Depakote (divalproex sodium) are more likely to have birth defects and other problems. Studies have demonstrated a strong link between Depakote and serious birth defects including Spina bifida, cleft palate, limb deformity, congenital cardiac defects, facial dysmorphism. Valproic acid, a well known anticonvulsant, is being used by psychiatrists increasingly to manage bipolar and other affective disorders. Because of the demographics of the population affected by such psychiatric conditions, more women... Read More

Transvaginal Mesh Implants


American Medication System(AMS) SETTLEMENT On April 30th, 2014 Audet & Partners, LLP  reached an agreement with AMS regarding resolution of its Mesh cases.  The firm represents hundreds of AMS mesh clients and was able to reach an excellent result for its AMS clients.  The firm expects to provide details regarding the settlement to its clients in the next few weeks, as well as to commence implementation of the settlement process with the goal of paying clients settlement amounts in the near... Read More

Risperdal Lawsuits Stress Demonstrated Link to Enlarged Breast Tissue in Males

Risperdal Lawyers

Audet & Partners, LLP is investigating claims for serious personal injuries, including breast enlargement in males, tied to administration of the antipsychotic drug Risperdal.  Commonly prescribed to treat schizophrenia and bipolar disorder, and occasionally used off-label to address ADHD, Risperdal has been shown in several studies over the past fifteen years to be strongly linked to elevated levels of prolactin in males, a hormonal precursor to breast development and lactation in women. This condition, referred to as Risperdal Gynecomastia, is irreversible.... Read More

Effexor Drug Birth Defects


Effexor® (venlafaxine) is an antidepressant selective serotonin reuptake inhibitor (SSRI) drug used by to treat depressive disorder, anxiety, and other of panic disorders. By design, the drug impacts chemicals in the users brain. For years, Wyeth, the manufacturer of Effexor, promoted the drug to female users as a way to make the patient ‘feel better’. A number of studies have raised serious concerns with the links between Effexor and birth defect for users who ingested the drug during pregnancy.  Animal... Read More

Actos Linked to Heart Failure and Bladder Cancer


Since the late 1990's, Actos (pioglitazone) has been prescribed to diabetes type 2 patients.  The drug was introduced by Takeda Pharmaceuticals, Japan's largest drug manufacturer.  Actos works by increasing bodily sensitivity to insulin.  Unfortunately, as thousands of pending lawsuits now allege, Actos also increases patient susceptibility to dire health consequences including heart failure and bladder cancer. Actos originally rose to market prominence when a similar drug, Avandia, was linked to heart attacks and strokes.  In following years, however, numerous studies have... Read More

Biomet Metal-on-Metal Hip Implant Lawsuits


Introduced in 2004 after an expedited review by the U.S. Food and Drug Administration ("FDA"), the Biomet M2a Hip Replacement device has since been linked to numerous serious side effects including metallosis, a condition resulting from elevated levels of metal ions being introduced into the bloodstream.  Several lawsuits have already been brought against Biomet alleging high levels of cobalt measured in patients with metal-on-metal hip implants such as the M2a Magnum. Elevated introduction of metal particles into the body from the... Read More

Mirena IUD Lawsuits


Mirena IUD, manufactured by Bayer, was approved by the FDA in 2000 as a contraceptive device recommended to women who have had at least one child. This small, t-shaped plastic device is inserted by a health care professional and can be left in place for up to five years. Among its marketing strategies for the Mirena IUD, Bayer held “Mirena Parties” for “busy moms” in connection with the social networking site Mom Central. At these gatherings, a representative from Mom Central... Read More

Fresenius Medical Care: GranuFlo and NaturaLyte Dialysis Products


The U.S. Food & Drug Administration recently declared a Class I recall of Fresenius Medical Care's GranuFlo and NaturaLyte dialysis products. After an internal Fresenius memo was leaked to the FDA, the company warned its customers that the products have been linked to elevated bicarbonate levels, a contributing factor in cardiac arrest.   According to the FDA website:   "FDA issued a Class I Recall notice for Fresenius Medical Care North America Naturalyte Liquid Acid Concentrate and Naturalyte GranuFlo (powder) Acid Concentrate. Inappropriate prescription... Read More

NuvaRing Contraceptive Ring Lawsuits

NuvaRing is the trade name for a combined hormonal contraceptive vaginal ring manufactured by Merck (formerly Schering-Plough, formerly Organon), that is available by prescription. It is a flexible plastic (ethylene-vinyl acetate copolymer) ring that releases a low dose of a progestinand estrogen over three weeks. It is considered to be a “third-generation” birth control method. Numerous lawsuits have been filed against the manufacturers, distributors, and marketers of the NuvaRing birth control vaginal ring, and recent court cases are now allowing these... Read More

Da Vinci Surgical Robot Lawsuits


Several hospital burn lawsuits involving the “da Vinci Surgical Robot” claim that a number of patients have suffered serious burns. One New York father filed a wrongful death hospital burn lawsuit after his daughter died as a result of burns caused by the robot. The lawsuit claims that the da Vinci robot caused burns to an artery and intestines when his daughter was having a hysterectomy in a Bronx hospital in August 2010. She died two weeks later. According to the... Read More

Fentanyl (Duragesic) Patch Investigation

Patches containing the prescription painkiller fentanyl have been recalled because of a flaw that could cause patients or caregivers to overdose on the potent drug inside. Sold in the United States under the brand name Duragesic by PriCara and generically by Sandoz Inc., the recall includes all 25-microgram-per-hour patches with expiration dates on or before December 2009. Some of the patches may have a cut in the lining of the internal reservoir where the drug is stored in gel form. If the fentanyl gel... Read More

Avastin Side Effects

The commissioner of the Food and Drug Administration recently revoked the approval of the drug Avastin as a treatment for breast cancer.   The commissioner, Dr. Margaret A. Hamburg, said that clinical trials had shown that the drug was not helping breast cancer patients to live longer or to meaningfully control their tumors, but did expose them to potentially serious side effects like severe high blood pressure and hemorrhaging. IF YOU HAVE SUFFERED ANY OF THE BELOW SERIOUS SIDE EFFECTS, PLEASE CONTACT... Read More

Levetiracetam (Generic Keppra) Investigations

Levetiracetam (also known as generic Keppra) is an anticonvulsant medication used to treat epilepsy.  It is also  used to treat simple and complex partial seizures and myclonic seizures as well as migraines, autism, social anxiety and neuropathic pain. Levetiracetam is marketed under the trade name Keppra. Keppra is manufactured by UCB Pharmaceuticals Inc. The generic drug Levetiracetam is manufactured by Mylan Laboratories, Inc. In many recent cases, pharmacies and/or prescribing doctors have allegedly switched patients over to the "generic" version of Keppra without... Read More

Plavix (clopidogrel bisulfate)


Plavix (clopidogrel bisulfate), distributed by Sanofi-Aventis and Bristol-Myers Squibb, is the second best-selling drug in the world. Doctors commonly prescribe this anti-coagulant in combination with aspirin as a preventative measure against strokes, heart attacks, and to promote a healthy circulatory system. However, researchers have recently found that Plavix use can actually greatly increase the risk of a stroke, gastrointestinal bleeding, heart attack, and other serious conditions. Plavix also appears to have certain other issues.  For example, according to published data, it... Read More

Raptiva and Progressive Multifocal Leukoencephalopathy (PML)

UPDATE: 04/09/2009: Audet & Partners, LLP, a San Francisco, California-based trial law firm, filed the first complaint against Genentech arising out of the recently announced withdrawal of Raptiva medication.  Filed in Alameda Superior Court, the complaint seeks general and punitive damages. Raptiva is a medication used to treat severe to moderate psoriasis and works by suppressing the immune system.  According to allegations in the complaint filed by Audet & Partners, LLP, Raptiva allegedly causes a number of serious life-threatening infections, including encephalitis,... Read More

Yaz, Yasmin, and Beyaz Birth Control Allegedly Shown To Cause Serious Injuries

Yasmin is the brand name for a birth control pill that is generically known as drospirenone.  It is also a treatment for moderate acne andpremenstrual dysphoric disorder (PMDD) in women.  It is produced by Bayer Healthcare.  Bayer Healthcare also manufactures “Yaz” birth control pills. The main difference between Yaz and Yasmin is in the level of estrogen contained in each pill compared to the level of progestins. Yasmin has brought Bayer Healthcare $487 million in sales in the US alone with $1.5... Read More

Trasylol (aprotinin injection) Heart Attacks and Stroke Lawsuit

Drug maker Bayer AG has recalled all remaining stocks of the antibleeding medication Trasylol (aprotinin) from the U.S. market after a New England Journal of Medicine Study demonstrated that the drug increased heart surgery patients' risk of death by 53 percent. Canadian researchers compared rates of massive bleeding, organ failure, death and other serious complications in 2,331 heart surgery patients given either Trasylol, Cyklokapron (tranexamic acid) or Amicar (aminocaproic acid). The anti-bleeding drugs are often prescribed during high-risk heart surgeries. The researchers found that while about 4 percent of surgery patients... Read More



Common Gadolinium-based Contrast Agents Linked to Nephrogenic Systemic Fibrosis (NSF): Magnevist, Ominiscan; OptiMARK; MultiHance; and Prohance   Introduction  The U.S. Food and Drug Administration (FDA) has asked manufacturers to include a new boxed warning on the product labeling of all gadolinium-based contrast agents which are used to enhance the quality of magnetic resonance imaging (MRI). The requested warning would state that patients with severe kidney insufficiency who receive gadolinium-based agents are at risk for developing a debilitating, and a potentially fatal disease known as... Read More


The intravenous drug Natrecor has been injected into over 600,000 patients across the nation to treat heart failure. Nesiritide is sold as Natrecor and is made by Scios Inc., a subsidiary of Johnson & Johnson. The medication was approved in 2001, but researchers recently discovered patients were more likely to die in the first month after treatment than if they were to have taken a placebo. Natrecor causes the relaxation and enlargement of blood vessels, which lowers blood pressure, especially... Read More